This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
KOF vs. FMX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
KOF vs. FMX: Which Stock Is the Better Value Option?
Are Investors Undervaluing Coca-Cola FEMSA (KOF) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FEMSA (FMX) Declines on Q4 Loss, Higher Operating Expenses
by Zacks Equity Research
FEMSA's (FMX) Q4 results reflect the impacts of the COVID-19 pandemic due to reduced consumer mobility and operating restrictions across its segments, particularly OXXO and OXXO Gas operations.
Monster Beverage's (MNST) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Monster Beverage's (MNST) Q4 top line gains from higher at-home consumption trends due to shift in consumer preferences for channel & packaging options, offset by the impacts on the on-premise channel.
Keurig Dr Pepper (KDP) Q4 Earnings Miss Estimates, Sales Beat
by Zacks Equity Research
Robust market share gains and better at-home consumption trends aid Keurig Dr Pepper's (KDP) sales in Q4. Dollar market share improve more than 90% of KDP's cold beverage retail base.
AB InBev (BUD) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
AB InBev's (BUD) Q4 results demonstrate its fundamental strength as well as continued resilience in the global beer category. Revenues benefit from the recovery in volume and revenue per hl.
Boston Beer (SAM) Dips on Q4 Earnings Miss, Revenues Beat
by Zacks Equity Research
Boston Beer's (SAM) Q4 revenues reflect gains from higher shipments and depletions, driven by a strong brand portfolio. Higher operating costs and a gross margin decline hurt earnings.
Coca-Cola FEMSA (KOF) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Coca-Cola FEMSA (KOF) has been struggling lately, but the selling pressure may be coming to an end soon
KOF vs. KO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
KOF vs. KO: Which Stock Is the Better Value Option?
PepsiCo (PEP) Surpasses Earnings & Revenue Estimates in Q4
by Zacks Equity Research
PepsiCo (PEP) reports strong Q4 results on continued momentum in the global snacks and foods business as well as gains in the beverage category. It witnesses organic revenue growth for all segments.
International Flavors (IFF) Q4 Earnings & Sales Top Estimates
by Zacks Equity Research
International Flavors' (IFF) Fine Fragrance returns to growth on new customer wins, while Food Service categories see declines due to the pandemic during the October-December quarter.
Coca-Cola (KO) Q4 Earnings Surpass Estimates, Sales Miss
by Zacks Equity Research
Coca-Cola's (KO) Q4 earnings reflect benefits from sequential improvements in volume trends. Pressures in away-from-home channels continue to impact results.
Is Coca-Cola FEMSA (KOF) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
KOF vs. PEP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
KOF vs. PEP: Which Stock Is the Better Value Option?
Diageo (DEO) 1H Earnings & Sales Reflect Sequential Gains
by Zacks Equity Research
Diageo (DEO) 1H FY21 sales and operating profit reflect sequential gains, owing to improved market share on growth in off-trade and partial reopening of the on-trade channel.
FEMSA (FMX) Fortifies Presence in US Specialized Distribution
by Zacks Equity Research
FEMSA (FMX) is on track to expand presence in the specialized distribution industry in the United States through the acquisition of two independent businesses in the industry.
FEMSA (FMX) Q3 Earnings Miss Estimates, Revenues Decline Y/Y
by Zacks Equity Research
FEMSA's (FMX) third-quarter 2020 results continued to reflect the impacts of the pandemic-led disruptions. However, it witnesses sequential recovery due to the easing of restrictions.
FEMSA (FMX) Q2 Earnings & Sales Down Y/Y on Coronavirus Woes
by Zacks Equity Research
FEMSA (FMX) second-quarter results reflect significant impacts of the coronavirus outbreak across all segments caused by restrictions on mobility, soft consumer demand and lower supplies.
New Strong Sell Stocks for July 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
FEMSA (FMX) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
FEMSA (FMX) delivers strong first-quarter 2020 results on robust top-line growth and higher operating income across most of its business units amid the coronavirus crisis.
New Strong Sell Stocks for April 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
KOF vs. KO: Which Stock Is the Better Value Option?
by Zacks Equity Research
KOF vs. KO: Which Stock Is the Better Value Option?
Brown-Forman (BF.B) Misses Q3 Earnings & Sales, Lowers View
by Zacks Equity Research
Brown-Forman's (BF.B) bottom line misses estimates in third-quarter fiscal 2020 on higher expenses and soft margins. It cuts view for fiscal 2020 on the probable impacts of the coronavirus outbreak.
Constellation Brands Concludes Divesture of Ballast Point
by Zacks Equity Research
Constellation Brands (STZ) concludes sale of the Ballast Point brand and related assets to Kings & Convicts. The divesture is in sync with the company's consumer-led premiumization strategy.
FEMSA (FMX) Q4 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
FEMSA's (FMX) Q4 earnings miss estimates on a decline in operating income at the FEMSA Comercio Health Division and Coca-Cola FEMSA. Top-line growth across most operations fuels total revenues.